Seoul, South Korea

Min Chul Park

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Seoul, KR (2014 - 2021)
  • Seongnam-si, KR (2022)
  • Gyeonggi-do, KR (2019 - 2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Min Chul Park: Innovator in Protein and Cancer Diagnostics

Introduction

Min Chul Park is a prominent inventor based in Seoul, South Korea, with an impressive portfolio of 15 patents. His groundbreaking work primarily revolves around advancements in protein research and its applications in medical diagnostics.

Latest Patents

Among his latest innovations, Park has developed a patent related to the AIMP1 protein fragment. This invention introduces novel fragments of the AIMP1 protein and a composition aimed at improving alopecia and promoting hair growth. The polypeptide consists of 4 to 21 consecutive amino acids from a specific amino acid sequence, particularly featuring the 28th to 31st amino acid residues (KEKA). This invention includes a polynucleotide encoding the polypeptide and various compositions for pharmaceutical, cosmetic, and food applications to combat hair loss.

Additionally, Park's patent for a colorectal cancer diagnostic composition and method stands out. This invention focuses on detecting diagnostic markers, particularly through measuring the mRNA levels of lysyl-tRNA synthetase (KRS) and AIMP1. By obtaining a sample from a test subject, physicians can determine if colorectal cancer is present, quickly and accurately, based on the expression levels of the markers compared to a normal control group.

Career Highlights

Min Chul Park has worked at notable institutions such as the Korea Institute of Science and Technology and the Medicinal Bioconvergence Research Center. His tenure at these organizations has contributed significantly to his expertise and innovations in the field of biomedical science.

Collaborations

Throughout his career, Park has collaborated with prominent individuals in his field, including Sunghoon Kim and Young Min Jhon. Their collective efforts have propelled advancements in protein research and medical diagnostics.

Conclusion

Min Chul Park's contributions to the field of biotechnology through his patents, particularly in protein research and colorectal cancer diagnostics, are commendable. His innovative spirit continues to influence the scientific community and provides hope for advancements in medical treatments and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…